Somalogic Inc
F:76X0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Somalogic Inc
Accounts Receivables
Somalogic Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Somalogic Inc
F:76X0
|
Accounts Receivables
$17m
|
CAGR 3-Years
59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accounts Receivables
$10.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Accounts Receivables
$3.8B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Waters Corp
NYSE:WAT
|
Accounts Receivables
$828.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Accounts Receivables
$1.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
Somalogic Inc
Glance View
SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company is headquartered in New York City, New York and currently employs 320 full-time employees. The company went IPO on 2021-02-23. The company develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein. The company offers SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. Its products include SomaScan Assay, SomaSignal Tests, SomaScan Panels, and SOMAmer Reagents. SomaScan Assay is utilized for Research Use Only (RUO) applications. Its SomaScan Assay measures approximately 7,000 protein target measurements in a single sample. SomaSignal Tests are available as laboratory developed tests (LDT) for use in obtaining proteomics information from patients and monitoring patients’ physiological states, among others. SomaScan Panels consists of two categories: fixed panels and custom panels. The company offers drug development, analysis of clinical trial and new human biology insights.
See Also
What is Somalogic Inc's Accounts Receivables?
Accounts Receivables
17m
USD
Based on the financial report for Dec 31, 2022, Somalogic Inc's Accounts Receivables amounts to 17m USD.
What is Somalogic Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 3Y
59%
Over the last year, the Accounts Receivables growth was -1%. The average annual Accounts Receivables growth rates for Somalogic Inc have been 59% over the past three years .
